NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA
Go back to NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA| (NASDAQ: IBRX) | Delayed: 8.71 +0.92 (11.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.79 | 52 Week High | $ | |||
| Open | $7.74 | 52 Week Low | $ | |||
| Day High | $8.85 | P/E | N/A | |||
| Day Low | $7.67 | EPS | $ | |||
| Volume | 41,152,616 | |||||
